Benzinga's Top Downgrades

Analysts at Oppenheimer downgraded General Finance Corporation GFN from Outperform to Perform. General Finance shares closed at $3.55 on Friday. Analysts at FBR Capital downgraded Atmel Corporation ATML from Outperform to Market Perform. The target price for Atmel has been lowered from $11 to $10.50. Atmel shares closed at $7.27 on Friday. Analysts at Deutsche Bank downgraded D.R. Horton, Inc. DHI from Buy to Hold. DR Horton shares closed at $31.61 on Friday. RBC Capital downgraded Precision Castparts Corp. PCP from Outperform to Sector Perform. The target price for Precision Castparts has been raised from $230 to $235. Precision Castparts shares closed at $228.75 on Friday. Morgan Stanley downgraded ZS Pharma Inc ZSPH from Overweight to Equal-weight. The target price for ZS Pharma is set to $67. ZS Pharma shares closed at $73.43 on Friday. RBC Capital downgraded Anheuser Busch Inbev SA (ADR) BUD from Outperform to Sector Perform. The target price for Anheuser-Busch InBev has been lowered from $107 to $100. Anheuser-Busch InBev shares closed at $114.35 on Friday. Analysts at Macquarie downgraded Tribune Publishing Co TPUB from undefined to Underperform. The target price for Tribune Publishing has been lowered from $12 to $8. Tribune Publishing shares closed at $10.59 on Friday. Analysts at Mizuho Securities downgraded Boston Properties, Inc. BXP from Buy to Neutral. The target price for Boston Properties has been lowered from $157 to $128. Boston Properties shares closed at $118.72 on Friday. B. Riley downgraded Rocky Brands Inc RCKY from Buy to Neutral. Rocky Brands shares closed at $17.94 on Friday. Analysts at Morgan Stanley downgraded ImmunoGen, Inc. IMGN from Equal-weight to Underweight. The target price for Immunogen has been lowered from $10 to $9. Immunogen shares closed at $14.65 on Friday.